A new targeted oral therapy is changing the landscape for people with hormone receptor positive, HER2 negative metastatic breast cancer, offering another option for those whose disease has progressed on prior treatment. This practical session will step through how the treatment works, when it is used and what makes its side effect profile distinct.
The Australian Government has announced $1 million to fund projects that build stronger networks between cancer services in outer metropolitan, regional, rural, and remote communities, and larger metropolitan centres.
Australia now has clarity it has never had before: 20,950 Australians are living with metastatic breast cancer — more than double what was previously understood. This new national estimate exposes decades of undercounting, underestimated need, and under-resourced care.
Don't miss out on our next Rare Cancers CoP meeting with respected bioethicist and public health scientist, Dr Evie Kendall, as she uncovers Challenging Conversations in Unfunded Therapy.
This webinar covered early breast cancer from Diagnosis to Targeted Therapies. "Absolutely great presentation and I’ve been to many! The content was spot on, Sam was engaging and the slides very well put together"
This clinical update features key medical articles from global journals with commentary from Bronwyn Jennings, the Gynae Oncology Clinical Nurse Consultant at Mater Hospital Brisbane, Australia and Chair of CNSA's Gynaecological Oncology Specialist Practice Network.
